Results 221 to 230 of about 1,757,150 (280)

Variants of the Ebola virus matrix protein VP40 have differential effects on oligomerization and plasma membrane interactions. [PDF]

J Biol Chem
Motsa BB, Bhowal B, Narkhede YB, Karki U, Ramirez VT, Eger SW, Wiest O, Chapagain PP, Stahelin RV.   +8 more
europepmc   +1 more source

Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Ebola and Marburg Viruses Using Recombinant Nucleoproteins

, 2001
Masayuki Saijo, Masahiro Niikura, Shigeru Morikawa, Thomas G. Ksiazek, Richard F. Meyer, C. J. Peters, Ichiro Kurane   +6 more
openalex   +1 more source

From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability. [PDF]

J Med Chem
Morales-Tenorio M, Lasala F, Garcia-Rubia A, Aledavood E, Heung M, Olal C, Escudero-Pérez B, Oquist P, Canales Á, Alonso C, Martínez A, Muñoz-Fontela C, Delgado R, Gil C.   +13 more
europepmc   +1 more source

Intelligent-Based Neural Networks and Optimal Control of Fractional Order Ebola Virus Dynamics

Muhammad Noor, Alam Md Nur, Shi-qing Zhang   +2 more
openalex   +1 more source

Queueing Technique for Ebola Virus Disease Transmission and Control Analysis

, 2016
Chinyere Ogochukwu Dike, Zaitul Marlizawati Zainuddin, Ikeme John Dike   +2 more
openalex   +2 more sources

Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site. [PDF]

iScience
Wang LL, Keiser P, Yang D, Seravalli J, Patten JJ, Eaton B, Anderson D, Liu Y, Holbrook MR, Smith AB, Davey RA, Xiang SH.   +11 more
europepmc   +1 more source

Extending mental health support to the survivors of Ebola virus disease by overcoming challenges. [PDF]

Germs
Shrivastava SR, Bobhate PS.
europepmc   +1 more source

Evaluating the impact of trade-offs in diagnostic test accuracy, time-to-isolation, and accessibility on outbreak response for the Ebola virus: a mathematical modeling study. [PDF]

BMC Infect Dis
Boer NA, Emperador DM, Eckerle I, Agogo E, Nichols BE.   +4 more
europepmc   +1 more source

Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies. [PDF]

Antibodies (Basel)
Shcherbakov DN, Isaeva AA, Mustaev EA.
europepmc   +1 more source